MMP-2 and MMP-9 were increased in the serum of colorectal cancer patients, and their diagnostic sensitivity was higher than that of other biomarkers currently used in clinical practice, such as CEA and CA19-9 [95]. Here, MMP2 is linked to colorectal cancer.